COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 2061: Articles 20601-20610  | Next

Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
Jagannathan, P., Andrews, J., Bonilla, H., Hedlin, H., Jacobson, K., Balasubramanian, V., Purington, N., Kamble, S., de Vries, C., Quintero, O., Feng, K., Ley, C., Winslow, D., Newberry, J., Edwards, K., Hislop, C., Choong, I., Maldonado, Y., Glenn, J., Bhatt, A., Blish, C., Wang, T., Khosla, C., Pinsky, B., Desai, M., Parsonnet, J., Singh, U.
10.1101/2020.11.18.20234161 — Posted: 2020-11-23
Diagnostic accuracy of two commercial SARS-CoV-2 Antigen-detecting rapid tests at the point of care in community-based testing centers
Berger, A., Ngo Nsoga, M.-T., Perez Rodriguez, F. J., Abi Aad, Y., Sattonnet, P., Gayet-Ageron, A., Jaksic, C., Torriani, G., Boehm, E., Kronig, I., Sacks, J. A., de Vos, M., Jacquerioz-Bausch, F., Chappuis, F., Kaiser, L., Schibler, M., Eckerle, I.
10.1101/2020.11.20.20235341 — Posted: 2020-11-23
The risk of COVID hospital admission and COVID mortality during the first COVID 19 wave with a special emphasis on Ethnic Minorities: an observational study of a single, deprived, multi ethnic UK health economy
Singh, B. M., Bateman, J., Viswanath, A., Klaire, V., Mahmud, S., Nevill, A. M., Dunmore, S. J.
10.1101/2020.11.20.20224691 — Posted: 2020-11-23
Quantifying the potential value of antigen-detection rapid diagnostic tests for COVID-19: a modelling analysis
Ricks, S., Kendall, E. A., Dowdy, D. W., Sacks, J. A., Schumacher, S. G., Arinaminpathy, N.
10.1101/2020.11.20.20235317 — Posted: 2020-11-23
Improved RT-PCR SARS-Cov2 results interpretation by indirect determination of cut-off cycle threshold value.
mokhtar, k. m.
10.1101/2020.11.20.20235390 — Posted: 2020-11-23
Antibody response patterns in COVID-19 patients with different levels of disease severity-Japan
Imai, K., Kitagawa, Y., Tabata, S., Kubota, K., Ikeda, M., Matuoka, M., Miyoshi, K., Sakai, J., Ishibashi, N., Tarumoto, N., Takeuchi, S., Ito, T., Maesaki, S., Tamura, K., Maeda, T.
10.1101/2020.11.20.20231696 — Posted: 2020-11-23
Antibody persistency and dynamic trend after SARS-CoV-2 infection over 8 months
Dehgani-Mobaraki, P., Kamber Zaidi, A., porreca, A., Floridi, A., Floridi, E.
10.1101/2020.11.21.20236117 — Posted: 2020-11-23
Duration of SARS-CoV-2 viral shedding in faeces as a parameter for wastewater-based epidemiology: Re-analysis of patient data using a shedding dynamics model
Miura, F., Kitajima, M., Omori, R.
10.1101/2020.11.22.20236323 — Posted: 2020-11-23
ANTIBODY RESPONSE TO COVID-19 INFECTION- CLINICAL VARIABLES AT PLAY
PARKASH, A., SINGLA, P., BHATIA, M.
10.1101/2020.11.20.20234500 — Posted: 2020-11-23
Dynamics of ORF1ab and N Gene among hospitalized COVID-19 positive cohorts: A hospital based retrospective study
Loying, P., Sarma, V., Hazarika, S. C., Kataki, M., Raja, D., Medhi, D., Dutta, R., Chena, A., Daimary, D., Choudhurydo, A., Saikia, L.
10.1101/2020.11.22.20236240 — Posted: 2020-11-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).